Global Population Genomic Screening Programs Market Report 2026 | Capitalize on 14.6% CAGR to 2030 as Illumina, Roche, Thermo Fisher and Natera Scale AI and Precision Medicine

What happened: ResearchAndMarkets.com added a report on the global population genomic screening programs market, covering program types, technologies, applications and end users across major regions. Key numbers: Market projected at $3.91 billion in 2025, rising to $4.47 billion in 2026 (14.3% CAGR), and forecast to reach $7.7 billion by 2030 at Why it matters: The report attributes growth to expanded adult and carrier screening, personalized medicine demand and AI adoption for genomic interpretation. North America was the largest region in 2025, with Asia-Pacific expected to grow fastest. Market: -0.3% today ($287.86), +114.3% YTD, 0.2x vol — as of 15:33 UTC Verified: Q3_2026 (Oct 29) EPS $1.36 vs $1.36 est; next print ~Jan 28

ResearchAndMarkets.com added a report on the global population genomic screening programs market, covering program types, technologies, applications and end users across major regions.

The report attributes growth to expanded adult and carrier screening, personalized medicine demand and AI adoption for genomic interpretation. North America was the largest region in 2025, with Asia-Pacific expected to grow fastest. Market: -0.3% today ($287.86), +114.3% YTD, 0.2x vol — as of 15:33 UTC Verified: Q3_2026 (Oct 29) EPS $1.36 vs $1.36 est; next print ~Jan 28